WFG Advisors, LP - RAPTOR PHARMACEUTICAL CORP ownership

RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 111 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q4 2015. The put-call ratio across all filers is 1.28 and the average weighting 0.1%.

Quarter-by-quarter ownership
WFG Advisors, LP ownership history of RAPTOR PHARMACEUTICAL CORP
ValueSharesWeighting
Q3 2015$1,000
-90.9%
145
-79.1%
0.00%
-100.0%
Q2 2015$11,000
+83.3%
695
+33.7%
0.00%
+50.0%
Q1 2015$6,000
+20.0%
5200.0%0.00%
+100.0%
Q4 2014$5,0000.0%520
+10.6%
0.00%0.0%
Q3 2014$5,0000.0%4700.0%0.00%0.0%
Q2 2014$5,000
+400.0%
470
+394.7%
0.00%
Q1 2014$1,0000.0%95
-5.0%
0.00%
Q4 2013$1,0001000.00%
Other shareholders
RAPTOR PHARMACEUTICAL CORP shareholders Q4 2015
NameSharesValueWeighting ↓
Broadfin Capital, LLC 7,000,000$32,200,0003.11%
SV Health Investors, LLC 888,132$4,085,0003.05%
Sarissa Capital Management LP 2,725,000$12,535,0002.76%
GREAT POINT PARTNERS LLC 1,346,344$6,193,0002.22%
Virtus ETF Advisers LLC 126,869$584,0000.80%
SPHERA FUNDS MANAGEMENT LTD. 400,000$1,840,0000.40%
TFS CAPITAL LLC 459,546$2,114,0000.30%
GLOBEFLEX CAPITAL L P 238,239$1,096,0000.29%
TURNER INVESTMENTS LLC 161,100$741,0000.20%
Birchview Capital, LP 40,000$184,0000.13%
View complete list of RAPTOR PHARMACEUTICAL CORP shareholders